Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) just unveiled an update.
Shanghai Haohai Biological Technology Co., Ltd. has announced the distribution and payment of an interim dividend for 2025, amounting to RMB0.40 per share, totaling RMB91,493,200.00. The dividend will be distributed to H Shareholders in Hong Kong Dollars, with payments scheduled for October 17, 2025. The company has also outlined tax arrangements for non-resident enterprise shareholders and individual holders of H shares, ensuring compliance with the Enterprise Income Tax Law of the People’s Republic of China.
The most recent analyst rating on (HK:6826) stock is a Buy with a HK$33.00 price target. To see the full list of analyst forecasts on Shanghai Haohai Biological Technology Co., Ltd. Class H stock, see the HK:6826 Stock Forecast page.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. The company operates in the biotechnology sector, focusing on the development and distribution of biological products.
Average Trading Volume: 724,660
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$13.11B
For a thorough assessment of 6826 stock, go to TipRanks’ Stock Analysis page.